Exploratory study of relation between efficacy and serum infliximab level, and predictors of response to infliximab dose escalation in patients with crohn's disease
Not Applicable
- Conditions
- Crohn's disease
- Registration Number
- JPRN-UMIN000014006
- Lead Sponsor
- IBD Center, Sapporo Kosei General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients whose age below 18 years old 2)Patients with serious infection (sepsis,etc) 3)Patients with active tuberculosis 4)Patients with history of allergy to ingredients of infliximab or to proteins derived from mouse 5)Patients with demyelinating diseases and its past history 6)Patients with congestive heart failure 7)Patients who are inadequate to enter this trial due to the other reasons by physician's judgments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method